What are the causes of dysglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Dysglycemia

Dysglycemia results from defects in insulin secretion, insulin action, or both, with the fundamental mechanism being deficient insulin action on target tissues. 1

Primary Pathophysiologic Mechanisms

The underlying causes of dysglycemia fall into two broad categories:

Inadequate Insulin Secretion

  • Autoimmune β-cell destruction (Type 1 diabetes): Autoimmune destruction of pancreatic β-cells leads to absolute insulin deficiency, identifiable by islet cell autoantibodies (GAD65, IA-2, ZnT8, insulin antibodies) and genetic markers (HLA-DQB1 and DRB1 haplotypes) 2
  • Progressive β-cell dysfunction (Type 2 diabetes): Inadequate compensatory insulin secretory response combined with insulin resistance 1
  • Pancreatic disease: Pancreatitis, trauma, cystic fibrosis, hemochromatosis, pancreatic carcinoma, or pancreatectomy causing extensive pancreatic damage 3

Insulin Resistance

  • Peripheral tissue resistance: Diminished tissue responses to insulin at multiple points in hormone action pathways, most commonly seen in Type 2 diabetes with obesity (especially abdominal adiposity) 4
  • Receptor abnormalities: Mutations in insulin receptor gene causing syndromes ranging from modest hyperglycemia to severe diabetes (Type A insulin resistance, leprechaunism, Rabson-Mendenhall syndrome) 3
  • Postreceptor defects: Alterations in signal transduction pathways, as seen in lipoatrophic diabetes 3

Secondary Causes

Endocrine Disorders

Hormone excess antagonizing insulin action:

  • Growth hormone excess (acromegaly)
  • Cortisol excess (Cushing's syndrome)
  • Glucagon excess (glucagonoma)
  • Catecholamine excess (pheochromocytoma)
  • Somatostatinoma and aldosteronoma (causing hypokalemia-induced insulin secretion inhibition) 3

Drug-Induced Dysglycemia

Most common cause in non-diabetic patients 5:

  • Glucocorticoids (most frequent)
  • Atypical antipsychotics
  • Thiazide diuretics
  • Nicotinic acid
  • High-dose statins
  • Immune checkpoint inhibitors
  • PI3 kinase inhibitors
  • Tacrolimus and octreotide
  • Interferon gamma 6

Hypoglycemia-Specific Causes

  • Insulin and insulin secretagogues (sulfonylureas, meglitinides): Most common cause of hypoglycemia 5, 7
  • Alcohol: Particularly in fasting states 5, 8
  • Insulinoma: Rare but most common hormone-secreting islet cell tumor, diagnosed by hypoglycemia with inappropriately elevated insulin (≥3.0 μU/mL) and C-peptide (≥0.6 ng/mL) during documented hypoglycemia 5, 9
  • Non-islet cell tumors: Large extrapancreatic mesenchymal tumors secreting IGF-II 8
  • Autoimmune hypoglycemia: Insulin or insulin-receptor autoantibodies 5, 8

Critical Illness and Organ Failure

  • Sepsis and septic shock (strongest predictor of hypoglycemia) 10
  • Renal failure: Both chronic kidney disease and acute kidney injury increase hypoglycemia risk 7, 10
  • Hepatic failure: Impaired gluconeogenesis 5, 8
  • Acute cardiac insufficiency 8

Nutritional and Metabolic Factors

  • Malnutrition: Particularly in hospitalized elderly patients with severe disease 8
  • Post-gastric surgery: Reactive hypoglycemia from excessive insulin response 9
  • Prolonged fasting 11

Important Clinical Caveats

Impairment of insulin secretion and defects in insulin action frequently coexist in the same patient, making it difficult to determine which abnormality is the primary cause 1. This overlap is particularly relevant when categorizing patients who may have features of both Type 1 and Type 2 diabetes 2.

In critical care settings, multiple factors often contribute simultaneously: disease severity (elevated SOFA score), insulin treatment, glucocorticoid use, low serum albumin, total parenteral nutrition, mechanical ventilation, and renal replacement therapy all independently increase dysglycemia risk 12, 10.

Gestational diabetes represents a distinct category where pregnancy-induced insulin resistance unmasks underlying β-cell dysfunction, requiring screening at 24-28 weeks gestation 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.